Related Experiment Videos
New treatment modalities for retinoblastoma
C L Shields1, J A Shields, P De Potter
1Ocular Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania 19107, USA.
Current Opinion in Ophthalmology
|May 7, 1996
Summary
Retinoblastoma management is shifting towards conservative treatments due to early detection and advanced therapies. While enucleation is used for advanced cases, focal treatments like chemotherapy and radiotherapy offer improved outcomes for intraocular retinoblastoma.
Area of Science:
- Ophthalmology
- Pediatric Oncology
Background:
- Retinoblastoma management has evolved over the past century.
- Recent trends favor focal conservative treatments over traditional methods.
Purpose of the Study:
- To review the evolving management strategies for retinoblastoma.
- To highlight the shift towards earlier detection and advanced focal treatment modalities.
Main Methods:
- Review of historical and recent advancements in retinoblastoma treatment.
- Discussion of various therapeutic modalities including surgery, radiotherapy, chemotherapy, and focal therapies.
Main Results:
- Early detection enables smaller tumor staging and more focused treatment.
- Enucleation remains crucial for advanced retinoblastoma with potential invasion.
- Focal treatments like plaque radiotherapy, cryotherapy, photocoagulation, thermotherapy, and chemothermotherapy show promise for smaller tumors.
- Systemic chemotherapy is effective for intraocular retinoblastoma and initial management.
Conclusions:
- The management of retinoblastoma has significantly advanced, with a growing emphasis on conservative and focal treatments.
- Integrated approaches combining systemic chemotherapy with focal therapies offer improved outcomes for intraocular retinoblastoma.